By Jessica Corso ( May 21, 2015, 6:23 PM EDT) -- The Federal Circuit handed down a pair of rulings Thursday in infringement cases involving patents for Novartis Pharmaceuticals Corp.'s Exelon Patch, saying that a Par Pharmaceutical Inc. generic did not infringe the patents but that a similar generic produced by Watson Laboratories Inc. did....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.